DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103,568 | +13.3% | 7,012 | -0.9% | 0.00% | – |
Q2 2023 | $91,384 | +17.7% | 7,073 | -10.7% | 0.00% | – |
Q1 2023 | $77,666 | -31.3% | 7,917 | -25.5% | 0.00% | – |
Q4 2022 | $113,072 | +289.9% | 10,627 | +271.2% | 0.00% | – |
Q3 2022 | $29,000 | -65.9% | 2,863 | -58.1% | 0.00% | – |
Q2 2022 | $85,000 | +286.4% | 6,836 | +241.8% | 0.00% | – |
Q1 2022 | $22,000 | +144.4% | 2,000 | 0.0% | 0.00% | – |
Q3 2020 | $9,000 | -97.5% | 2,000 | -89.4% | 0.00% | – |
Q4 2017 | $353,000 | -42.1% | 18,934 | -33.3% | 0.00% | -100.0% |
Q3 2017 | $610,000 | +30400.0% | 28,369 | +17630.6% | 0.00% | – |
Q2 2016 | $2,000 | -33.3% | 160 | -4.2% | 0.00% | – |
Q1 2016 | $3,000 | -40.0% | 167 | -11.6% | 0.00% | – |
Q4 2015 | $5,000 | -97.8% | 189 | -98.0% | 0.00% | – |
Q3 2015 | $227,000 | -39.0% | 9,229 | -41.8% | 0.00% | – |
Q2 2015 | $372,000 | +3.9% | 15,863 | -0.7% | 0.00% | – |
Q1 2015 | $358,000 | +32.6% | 15,979 | 0.0% | 0.00% | – |
Q4 2014 | $270,000 | – | 15,979 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |